Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Beyer

Showing results (41-50 of 225) with videos related to

Pageof 23
Sort By:
International Journal of Cardiology|January 8, 2018
The CHA<sub>2</sub>DS<sub>2</sub>-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney diseaseJan Beyer-Westendorf, Reinhold Kreutz, Florian Posch, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 19, 2015
Erratum to: Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)Sebastian Werth, Tomás Breslin, Fionnuala NiAinle, et al.
Physical Chemistry Chemical Physics : PCCP|May 1, 2020
Comparing the optical properties and thermal stability of green (TbPO<sub>4</sub>), yellow (DyPO<sub>4</sub>), and red (PrPO<sub>4</sub>) emitting single crystal samplesSuchinder K Sharma, Jan Beyer, Richard Gloaguen, et al.
Physical Chemistry Chemical Physics : PCCP|November 16, 2019
Non-quenching photoluminescence emission up to at least 865 K upon near-UV excitation in a single crystal of orange-red emitting SmPO<sub>4</sub>Suchinder K Sharma, Jan Beyer, Richard Gloaguen, et al.
Hamostaseologie|April 30, 2024
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k GuidelineRobert Klamroth, Hanno Riess, Jan Beyer-Westendorf, et al.
British Journal of Clinical Pharmacology|March 12, 2011
Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinuxJan Beyer-Westendorf, Sebastian Werth, Gunnar Folprecht, et al.
British Journal of Clinical Pharmacology|February 17, 2025
Adherence and persistence with direct oral anticoagulants by dose regimen: A systematic reviewRaúl Quirós López, Francesc Formiga Pérez, Jan Beyer-Westendorf
Hamostaseologie|December 4, 2024
Challenging Situations in the Treatment of Cancer-Associated ThrombosisEkaterina Balaian, Sandra Marten, Jan Beyer-Westendorf, et al.
Minerva Anestesiologica|April 20, 2023
Bleeding management in patients with direct oral anticoagulantsLars Heubner, Oliver Vicent, Jan Beyer-Westendorf, et al.
Thrombosis and Haemostasis|August 28, 2007
Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatrobanJan Beyer, Kai Halbritter, Matthias Weise, et al.
Pageof 23

Showing results (41-50 of 225) with videos related to

Sort By:
Pageof 23
International Journal of Cardiology|January 8, 2018
The CHA<sub>2</sub>DS<sub>2</sub>-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney diseaseJan Beyer-Westendorf, Reinhold Kreutz, Florian Posch, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 19, 2015
Erratum to: Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)Sebastian Werth, Tomás Breslin, Fionnuala NiAinle, et al.
Physical Chemistry Chemical Physics : PCCP|May 1, 2020
Comparing the optical properties and thermal stability of green (TbPO<sub>4</sub>), yellow (DyPO<sub>4</sub>), and red (PrPO<sub>4</sub>) emitting single crystal samplesSuchinder K Sharma, Jan Beyer, Richard Gloaguen, et al.
Physical Chemistry Chemical Physics : PCCP|November 16, 2019
Non-quenching photoluminescence emission up to at least 865 K upon near-UV excitation in a single crystal of orange-red emitting SmPO<sub>4</sub>Suchinder K Sharma, Jan Beyer, Richard Gloaguen, et al.
Hamostaseologie|April 30, 2024
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k GuidelineRobert Klamroth, Hanno Riess, Jan Beyer-Westendorf, et al.
British Journal of Clinical Pharmacology|March 12, 2011
Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinuxJan Beyer-Westendorf, Sebastian Werth, Gunnar Folprecht, et al.
British Journal of Clinical Pharmacology|February 17, 2025
Adherence and persistence with direct oral anticoagulants by dose regimen: A systematic reviewRaúl Quirós López, Francesc Formiga Pérez, Jan Beyer-Westendorf
Hamostaseologie|December 4, 2024
Challenging Situations in the Treatment of Cancer-Associated ThrombosisEkaterina Balaian, Sandra Marten, Jan Beyer-Westendorf, et al.
Minerva Anestesiologica|April 20, 2023
Bleeding management in patients with direct oral anticoagulantsLars Heubner, Oliver Vicent, Jan Beyer-Westendorf, et al.
Thrombosis and Haemostasis|August 28, 2007
Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatrobanJan Beyer, Kai Halbritter, Matthias Weise, et al.
Pageof 23